maveron
Auto Added by WPeMatico
It’s a new era for fertility tech
Women’s health has long been devoid of technological innovation, but when it comes to fertility options, that’s starting to change. Startups in the space are securing hundreds of millions in venture capital investment, a significant increase to the dearth of funding collected in previous years.
Fertility entrepreneurs are focused on a growing market: couples are choosing to reproduce later in life, an increasing number of female breadwinners are able to make their own decisions about when and how to reproduce, and overall, around 10% of women in the US today have trouble conceiving, according to the Centers for Disease Control and Prevention.
Startups, as a result, are working to improve various pain points in a women’s fertility journey, whether that be with new-age brick-and-mortar clinics, information platforms, mobile applications, wearables, direct-to-consumer medical tests or otherwise.
Although the investment numbers are still relatively small (compared to, say, scooters), the trend is up — here’s the latest from founders and investors in the space.
VCs want to help you get pregnant
Clue, a period and ovulation-tracking app, co-founder and CEO Ida Tin talks at TechCrunch Disrupt Berlin 2017 (Photo by Noam Galai/Getty Images for TechCrunch)
This fall, TechCrunch received a tip that SoftBank, a prolific venture capital firm known for its nearly $100 billion Vision Fund, was investing in Glow, a period-tracking app meant to help women get pregnant. Max Levchin, Glow’s co-founder and a well-known member of the PayPal mafia, succinctly responded to a TechCrunch inquiry regarding the deal via e-mail: “Fairly sure you got this particular story wrong,” he wrote. Glow co-founder and chief executive officer Mike Huang did not respond to multiple requests for comment at the time.
Needless to say, some semblance of a SoftBank fertility deal got this reporter interested in a space that seldom populates tech blogs.
Femtech, a term coined by Ida Tin, the founder of another period and ovulation-tracking app Clue, is defined as any software, diagnostics, products and services that leverage technology to improve women’s health. Femtech, and more specifically the businesses in the fertility and contraception lanes, hasn’t made headlines as often as AI or blockchain technology has, for example. Probably because companies in the sector haven’t closed as many notable venture deals. That’s changing.
The global fertility services market is expected to exceed $21 billion by 2020, according to Technavio. Meanwhile, private investment in the femtech space surpassed $400 million in 2018 after reaching a high of $354 million the previous year, per data collected from PitchBook and Crunchbase. This year already several companies have inked venture deals, including men’s fertility business Dadi and Extend Fertility, which helps women freeze their eggs.
“In the last three to six months, it feels like investor interest has gone through the roof,” Jake Anderson-Bialis, co-founder of FertilityIQ and a former investor at Sequoia Capital, told TechCrunch. “It’s three to four emails a day; people are coming out of the woodwork. It feels like somebody shook the snow globe here and it just hasn’t stopped for months now.”
Dadi, Extend Fertility and FertilityIQ are among a growing list of startups in the fertility space to crop up in recent years. FertilityIQ, for its part, provides a digital platform for fertility patients to research and review doctors and clinics. The company also collects data and issues reports, like this one, which ranked businesses by fertility benefits. Anderson-Bialis launched the platform with his wife, co-founder Deborah Anderson-Bialis, in 2016 after the pair overcame their own set of infertility issues.
Anderson-Bialis said he has recently fielded requests from seed, Series A and growth-stage investors interested in exploring the growing fertility market. His company, however, has yet to raise any outside capital. Why? He doesn’t see FertilityIQ as a venture-scale business, but rather a passion project, and he’s skeptical of the true market opportunity for other businesses in the space.
Powered by WPeMatico
Two Chairs nabs $7M for its client-therapist matching app and brick-and-mortar clinics
The future of healthcare isn’t entirely digital. For encounters as intimate as the client-therapist dynamic, a face-to-face relationship is still key.
For those able to afford tech-enabled therapy services, Two Chairs, a San Francisco-headquartered mental healthcare business, may be of interest. The startup believes in the power of in-person therapy, as opposed to the new variety of affordable digital tools meant to replace or coexist with therapy services. Today, the company is announcing a $7 million Maveron-led Series A financing to open additional brick-and-mortar clinics and build out its client-therapist matching app, which leverages technology to pair its customers with a therapist best-tailored to their needs.
The company currently operates four clinics in the Bay Area, where patients can access individual or group therapy. Each of those clinics was built with modern, young professionals in mind using “thoughtful design” to create “non-judgmental spaces.”
A Two Chairs clinic, which emphasizes “non-judgmental” design
The app and clinic interior design are the key differences between Two Chairs and a neighborhood private practice, it says. As far as pricing, at $180 an hour, a session doesn’t differ terribly from a typical session at a Bay Area private practice. The startup currently employs 30 therapists, who also are available over video chat should a client be sick or traveling, with a customer base of “several thousand.”
Two Chairs was founded in 2017 by former Palantir employee Alex Katz (pictured). In a conversation with TechCrunch, Katz admitted procuring real estate for Two Chairs’ brick-and-mortar clinics has been an expensive and difficult endeavor. It’s no wonder venture capitalists tend to favor IT startups devoid of the overhead costs associated with firms in the real estate business. Katz is hoping the latest investment, which brings Two Chairs’ total raised to $8 million, will help the business quickly sign additional leases outside of the most expensive city in the U.S.
The cash will also be used to advance Two Chairs’ matching app. The app surveys potential clients on their history, preferences and goals, then uses a library of data to match the client with the most suitable therapist in its roster and to create a customized treatment plan. Katz says they’ve provided clients with an accurate match 95 percent of the time.
“We know that the client-therapist relationship is the best predictor of an outcome with care and while it sounds intuitive, matching is not a concept that has existed in the mental health field historically,” Katz told TechCrunch.
Two Chairs is one of several mental health startups to capture the attention of venture capitalists lately. Basis, which helps people cope with anxiety and depression through guided conversations via chat and video, emerged from stealth in 2018 with a $3.75 million investment led by Bedrock. Wisdo, a community-focused app that connects people seeking help with those who can offer help, brought in an $11 million investment in December and emotional well-being app Aura raised $2.7 million from Cowboy Ventures in October.
Those three businesses have one thing in common: they are digital-first endeavors looking to innovate on top of a broken mental healthcare model. Two Chairs’ plan to build additional therapy clinics, however, doesn’t feel particularly inventive. Opening a chain of therapy offices, rather, sounds like a hard-to-scale, expensive business idea.
As for the uptick in capital for mental health tech, Katz is satisfied Silicon Valley has finally acknowledged the problem: “I think Silicon Valley venture has had a preference for models that don’t involve brick-and-mortar and minimize the use of people; they prefer software businesses,” he said. “The reason we are taking this approach is we know from the research that really well-matched in-person therapy is really effective. Still, at a high level, it’s exciting. There are a lot of people thinking in innovative ways of how we can provide improved mental healthcare.”
Goldcrest Capital also participated in Two Chairs’ Series A.
Powered by WPeMatico
Pro.com raises $33M for its home improvement platform
Pro.com is basically a general contractor for the age of Uber and Prime Now. While the company started as a marketplace for hiring home improvement professionals, it has now morphed into a general contractor and serves Denver, Phoenix, San Francisco, San Jose and Seattle. Today, Pro.com announced that it has raised a $33 million Series B round led by WestRiver Group, Goldman Sachs and Redfin. Previous investors DFJ, Madrona Venture Group, Maveron and Two Sigma Ventures also participated.
WestRiver founder Erik Anderson, Redfin CEO Glenn Kelman and former Microsoft exec Charlotte Guyman are joining the Pro.com board.
“Many of Redfin’s customers struggle to get professional renovation services, so we know firsthand that Pro.com’s market opportunity is massive,” writes Redfin’s Kelman. “Pro.com and Redfin share a commitment to combining technology and local, direct services to best take care of customers.”
The company tells me that the round caps off a successful 2018, where Pro.com saw its job bookings grow by 275 percent over 2017, a number that was also driven by its expansion beyond the Seattle market (as well as the good economic climate that surely helped in driving homeowners to tackle more home improvement projects). The company now has 125 employees.
With this funding round, Pro.com has now raised a total of $60 million. It’ll use the funding to enter more markets, with Portland, Oregon being next on the list, and expand its team as it goes along.
It’s no secret that the home improvement market could use a bit of a jolt. The market is extremely local and fragmented — and finding the right contractor for any major project is a long and difficult process, where the outcome is never quite guaranteed. The process has enough vagaries that many people never get around to actually commissioning their projects. Pro.com wants to change that with a focus on transparency and technology. That’s a startup that’s harder to scale than the marketplace the company started out with, but it also gives the company a chance to establish itself as one of the few well-known brands in this space.
Powered by WPeMatico
TrueFacet, which sells pre-owned, authenticated watches and jewelry, is raising a $10 million round of funding
The secondary luxury goods market has been growing wildly in recent years, with more shoppers opting to both sell their lightly used luxury goods like clothing and jewelry for cold, hard cash, as well as buying the pre-owned, authenticated luxury goods of others.
One of the biggest beneficiaries of the trend is The RealReal, a nearly eight-year-old shopping destination for the growing population of people who might not be willing or able to purchase a new Hermes Birkin bag but are willing to buy one in like-new condition for considerably less. The idea — which seems to be working — is to create a virtuous cycle, wherein the bag’s original purchaser receives the bulk of that re-sale price, then uses the money to buy another new handbag (or a used one) that can be resold at a later point in time.
Another beneficiary of the trend: TrueFacet, a five-year-old, New York-based marketplace that claims to have more than 40,000 watches and 55,000 pieces of pre-owned authenticated watches and jewelry for sale at its site, and that has more recently begun offering pre-owned timepieces directly through brands like Fendi Timepieces, Raymond Weil and Roberto Coin that now partner with TrueFacet to carry their pre-owned timepieces with a manufacture warranty.
Apparently, shoppers are buying what they’re collectively selling. The company, which had previously raised $14.7 million in funding from investors, looks to be closing in on another $10 million round, judging by freshly filed SEC paperwork that shows it has so far raised $7 million in funding and is targeting $9.8 million altogether.
TrueFacet’s backers include Founders Co-op, Freestyle Capital and Maveron, led by partner Jason Stoffer, who also happens to sit on the board of Dolls Kill, an edgy clothing marketplace that we wrote about on Monday.
TrueFacet has some tough competition in the space, including Crown & Caliber, a six-year-old, Atlanta, Ga.-based company that has never announced outside funding, and 15-year-old, Germany-based Chrono24, which has raised €21 million over the years. Both sell timepieces alone, however.
It also competes directly with The RealReal, which has raised nearly $300 million from investors and sells clothing and high-end home decor, as well as jewelry and watches. (The company doesn’t break out publicly which of these categories outpace the others in terms of sales.)
Interestingly, like The RealReal, which now operates permanent offline stores in both New York and L.A., TrueFacet is also crossing the chasm into the offline world, though it’s taking baby steps toward that end.
Specifically, earlier this month, it announced a partnership with Stephen Silver Fine Jewelry, which sells timepieces to many monied Bay Area VCs and other Silicon Valley bigs at stores in Redwood City and Menlo Park, Calif. For the time being at least, the jeweler will also sell pieces from TrueFacet’s collection.
Powered by WPeMatico
Dolls Kill is raising up to $15 million for its edgy fashion brand made for ‘misfits’
When founder Bobby Farahi met Shaudi “Shoddy” Lynn, it was at a rave in L.A. Farahi has said he was immediately drawn to the fashion sense of Lynn, who was a DJ at the time; she, meanwhile, might have appreciated the business acumen of Farahi, who had already sold a broadcast monitoring service called Multivision to a rival company.
As Farahi told Inc. magazine several years ago, the couple, now married, decided to try their hand at business together, calling it Dolls Kill and selling foxtail keychains before eventually evolving the brand into an online boutique that sells edgy, risqué clothes and accessories from companies like Killstar and Motel, both in the U.K., as well as makeup from another London company called Skinnydip.
Shoppers like what they see, seemingly. Back in 2014, Inc. reported, Dolls Kill, which is based in San Francisco, generated $7.6 million in sales. It was enough to elicit the attention of the consumer-focused venture firm Maveron, which wrote the company a check for $5 million. Now, shows an SEC filing, seven-year-old Dolls Kill is raising $15 million in new equity funding, and it has secured at least $10.7 million toward that end.
Some of that capital is seemingly being used to test out offline stores. Dolls Kill already has one brick-and-mortar store in San Francisco’s famous Haight neighborhood. In August, the company opened a second concept store in a 6,000-square-foot space on Fairfax Avenue in Los Angeles.
Dolls Kill is sometimes likened to Nasty Gal, founded in 2006 by Sophia Amoruso. Nasty Gal had filed for bankruptcy protection in 2016 after raising tens of millions of dollars from investors and reportedly spending heavily on marketing; two storefronts in L.A.; a downtown L.A. headquarters that quadrupled the size of an earlier HQ; and a fulfillment center in Kentucky.
At the time, industry analyst Richie Siegel told the L.A. Times that a central challenge to the company’s growth was Nasty Gal’s target market, suggesting that there is a ceiling to the number of women to whom a brand like Nasty Gal appeals. The company, since acquired by British online retailer Boohoo, continues as an online business only.
Powered by WPeMatico
Keeps parent company Thirty Madison raises $15 million to fight male pattern baldness
Thirty Madison, the healthcare startup behind the hair loss brand Keeps, has brought in a $15.25 million Series A co-led by Maveron and Northzone.
The company provides a subscription-based online marketplace for men’s hair loss prevention medications Finasteride and Minoxidil. Keeps sells these drugs direct-to-consumer, working with manufacturers to keep the costs low.
On Keeps, a subscription of Minoxidil, an over-the-counter topical treatment often referred to by the brand name Rogaine, is $10 monthly. A subscription to Finasteride, a prescription drug taken daily, is $25 per month.
“It’s an end-to-end platform that is the single best place for guys who are looking to keep their hair,” Thirty Madison co-founder Steven Gutentag told TechCrunch.
Keeps is tapping into a big market. According to the American Hair Loss Association, two-thirds of American men experience some hair loss by the age of 35.
You may have heard of Hims, a venture-backed men’s healthcare company that similarly sells subscriptions to hair loss treatments, as well as oral care, skin care and treatments for erectile dysfunction. Keeps is its smaller competitor. For now, the company is focused solely on haircare, though with the new funds, Thirty Madison plans to launch Cove, a sister brand to Keeps that will provide treatments to migraine sufferers.
The company was founded last year by Gutentag and Demetri Karagas with a plan to develop several digital healthcare brands under the Thirty Madison umbrella.
“Going through this process myself of starting to experience hair loss, I was not sure where to turn,” Gutentag said. “I went online and looked up ‘why am I losing my hair,’ and if you search on Google, really for any medical condition, you usually walk away thinking you’re going to die … I was so fortunate that I got access to this high-quality specialist who could help me with my problem and I was in the position to afford those treatments, but most people don’t get that access.”
Keeps also provide digital access to a network of doctors at a cost of roughly $30 per visit.
TechCrunch’s Connie Loizos wrote last year that “it’s never been a better time to be a man who privately suffers from erectile dysfunction, premature ejaculation or hair loss” because of advances and investments in telemedicine. Since then, even more money has been funneled into the space.
Hims has raised nearly $100 million to date and is rumored to be working on a line of women’s products. Roman, a cloud pharmacy for erectile dysfunction, raised an $88 million Series A last month and is launching a “quit smoking kit.” And Lemonaid Health, which also provides prescriptions to erectile dysfunction medications and more, secured $11 million last year.
Greycroft, Steadfast Venture Capital, First Round, ERA, HillCour and Two River also participated in Thirty Madison’s fundraise, which brings its total raised to date to $22.75 million.
Powered by WPeMatico